Insights

Expansion opportunity Zydus Group is actively expanding manufacturing capabilities internationally, including a planned four-acre facility in Sri Lanka with over $20 million investment, signaling a potential need for global supply chain, contract manufacturing partnerships, and regional regulatory support services.

Biosimilar push Launch of Tishtha, a nivolumab biosimilar, indicates a strategic move into immuno-oncology manufacturing and commercialization, presenting opportunities for partnerships in biosimilar development, quality systems, clinical support, and market access strategies.

Rare disease portfolio Acquisition of Sentynl Therapeutics and its FDA-approved rare-disease therapies suggests appetite for specialty manufacturing capabilities, regulatory affairs expertise, and distribution arrangements to support niche, high-value products.

Strategic alliances MoU with Guardant Health to offer the Shield Multi-Cancer Detection test in India demonstrates a channel for collaborative lab services, precision oncology testing partnerships, and integrated healthcare delivery opportunities.

Profitability pressure Q1 FY27 results show a decline in net profit despite revenue growth, highlighting potential demand for cost optimization services, manufacturing efficiency upgrades, and value-based partnerships to sustain margins while expanding product lines.

Similar companies to Zydus Group

Zydus Group Tech Stack

Zydus Group uses 8 technology products and services including Alteryx, Google Ads, Qlik, and more. Explore Zydus Group's tech stack below.

Media & News

Zydus Group's Email Address Formats

Zydus Group uses at least 5 email formats:
Zydus Group Email FormatsExamplePercentage
First.Last@zyduslife.comJohn.Doe@zyduslife.com
100%
FirstLast@zyduscadila.comJohnDoe@zyduscadila.com
58%
First.Last@zyduscadila.comJohn.Doe@zyduscadila.com
39%
FirstLas@zyduscadila.comJohnDoe@zyduscadila.com
2%
Last.First@zyduscadila.comDoe.John@zyduscadila.com
1%

Frequently Asked Questions

What is Zydus Group's phone number?

Minus sign iconPlus sign icon
You can contact Zydus Group's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Zydus Group's official website and social media links?

Minus sign iconPlus sign icon
Zydus Group's official website is zyduslife.com and has social profiles on LinkedIn.

How much revenue does Zydus Group generate?

Minus sign iconPlus sign icon
As of October 2026, Zydus Group's annual revenue is estimated to be $1B - $10B.

What is Zydus Group's NAICS code?

Minus sign iconPlus sign icon
Zydus Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Zydus Group have currently?

Minus sign iconPlus sign icon
As of October 2026, Zydus Group has approximately 22K employees across 6 continents, including Asia, North America and Africa. Key team members include Chief Executive Officer: H. W., Ceo: N. V. and Chief Executive Officer: S. P. Explore Zydus Group's employee directory with LeadIQ.

What industry does Zydus Group belong to?

Minus sign iconPlus sign icon
Zydus Group operates in the Pharmaceutical Manufacturing industry.

What technology does Zydus Group use?

Minus sign iconPlus sign icon
Zydus Group's tech stack includes Alteryx, Google Ads, Qlik, Salesforce, Oracle Database, Azure DevOps, Microsoft 365 and Microsoft Active Directory.

What is Zydus Group's email format?

Minus sign iconPlus sign icon
Zydus Group's email format typically follows the pattern of First.Last@zyduslife.com. Find more Zydus Group email formats with LeadIQ.

How much funding has Zydus Group raised to date?

Minus sign iconPlus sign icon
As of October 2026, Zydus Group has raised $7M in funding. The last funding round occurred on Apr 30, 2013.

When was Zydus Group founded?

Minus sign iconPlus sign icon
Zydus Group was founded in 1952.
Zydus Group logo

Zydus Group

Pharmaceutical ManufacturingGujarat, India10001+ Employees

Zydus Group is a global pharmaceutical manufacturing company based in Ahmedabad, Gujarat, India. It operates across the life sciences spectrum, engaging in the discovery, development, manufacture, and marketing of a broad range of healthcare therapies. The organization pursues its mission to help people live healthier lives through quality healthcare solutions and advances in life sciences.

Its activities serve healthcare providers and patients in multiple markets by delivering therapies across various medical needs. In May 2026, the group announced a partnership with Sakar Healthcare to supply oncology products in GCC countries and other emerging markets, illustrating its ongoing international collaboration.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1952
Employees
10001+

Section iconFunding & Financials

  • $7M

    Zydus Group has raised a total of $7M of funding over 1 rounds. Their latest funding round was raised on Apr 30, 2013 as a Post IPO Equity.

  • $1B - $10B

    Zydus Group's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.